research
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain tumors has not been elucidated yet, and it is difficult to treat patients because the tumors do not respond to existing antiepileptic drugs and debilitate children’s development.
A research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors. Their research results were published online in Nature Medicine on September 17.
The research team studied patients’ tissue diagnosed with ganglioglioma (GG), one of the main causes of tumor-associated intractable epilepsy, and found that the BRAF V600E somatic mutation is involved in the development of neural stem cells by using deep DNA sequencing. This mutation was carried out in an animal model to reproduce the pathology of GG and to observe seizures to establish an animal model for the treatment of epileptic seizures caused by pediatric brain tumors.
Using immunohistochemical and transcriptome analysis, they realized that the BRAF V600E mutation that arose in early progenitor cells during embryonic brain formation led to the acquisition of intrinsic epileptogenic properties in neuronal lineage cells, whereas tumorigenic properties were attributed to a high proliferation of glial lineage cells exhibiting the mutation. Notably, researchers found that seizures in mice were significantly alleviated by intraventricular infusion of the BRAF V600E inhibitor, Vemurafenib, a clinical anticancer drug.
The authors said, “Our study offers the first direct evidence that the BRAF somatic mutation arising from neural stem cells plays a key role in epileptogenesis in the brain tumor. This study also showed a new therapeutic target for tumor-associated epileptic disorders.”
In collaboration with the KAIST startup company, SoVarGen, the research team is currently developing innovative therapeutics for epileptic seizures derived from pediatric brain tumors. This study was supported by the Suh Kyungbae Foundation (SUHF) and the Citizens United for Research in Epilepsy.
(Figure: Preoperative and postoperative brain MRI (left panel), tumor H&E (right upper panel) and GFAP immunohistochemical (right lower panel) staining images from a patient with ganglioglioma (GG231) carrying the BRAFV600E mutation. The white arrow and the black arrowhead indicate the brain tumor and a dysplastic neuron, respectively.)
-
event 2025 KAIST Global Entrepreneurship Summer School Concludes Successfully in Silicon Valley
The “2025 KAIST Global Entrepreneurship Summer School (2025 KAIST GESS),” organized by the Office of Global Initiative of the KAIST International Office (Vice President So Young Kim), successfully concluded. Now in its fourth year, the program was designed to provide KAIST students with firsthand experience of the world’s leading startup ecosystem in Silicon Valley, USA, and to strengthen their practical capabilities to take on challenges on the global stage. This year&rsqu
2025-07-01 -
event 2025 KAIST Global Entrepreneurship Summer School Concludes Successfully in Silicon Valley
The “2025 KAIST Global Entrepreneurship Summer School (2025 KAIST GESS),” organized by the Office of Global Initiative of the KAIST International Office (Vice President So Young Kim), successfully concluded. Now in its fourth year, the program was designed to provide KAIST students with firsthand experience of the world’s leading startup ecosystem in Silicon Valley, USA, and to strengthen their practical capabilities to take on challenges on the global stage. This year&rsq
2025-07-01 -
research KAIST Develops AI to Easily Find Promising Materials That Capture Only CO₂
< Photo 1. (From left) Professor Jihan Kim, Ph.D. candidate Yunsung Lim and Dr. Hyunsoo Park of the Department of Chemical and Biomolecular Engineering > In order to help prevent the climate crisis, actively reducing already-emitted CO₂ is essential. Accordingly, direct air capture (DAC) — a technology that directly extracts only CO₂ from the air — is gaining attention. However, effectively capturing pure CO₂ is not easy due to water vapor (H₂O) present in the air. KAIST r
2025-06-29 -
people KAIST Invites World-Renowned Scholars, Elevating Global Competitiveness
< Photo 1. (From left) Professor John Rogers, Professor Gregg Rothermel, Dr. Sang H. Choi > KAIST announced on June 27th that it has appointed three world-renowned scholars, including Professor John A. Rogers of Northwestern University, USA, as Invited Distinguished Professors in key departments such as Materials Science and Engineering. Professor John A. Rogers (Northwestern University, USA) will be working with the Department of Materials Science and Engineering from July 2025 to J
2025-06-27 -
research New and Highly Efficient Recycling Technology to Turn Used Tires into Raw Materials for Rubber and Nylon
< (From left) Kyungmin Choi (MS-Ph.D. integrated course, Department of Chemistry), Dr. Beomsoon Park, Professor Soon Hyeok Hong, Dr. Kyoungil Cho > Approximately 1.5 billions of tires are discarded globally every year, and this is identified as one of the major causes of serious environmental pollution. The research team at the Department of Chemistry at KAIST has achieved a breakthrough by selectively converting waste tires into high-purity cyclic alkenes, valuable chemical buildin
2025-06-26